Tag Archives: Home

Hope For The Warriors Grants Support to Local Veteran through Home, NASCAR and More


MARTINSVILLE, VA (PRWEB) October 23, 2014

NASCAR driver, Ryan Newman, driver of #31, will show his support to a local wounded veteran this weekend at the Martinsville Speedway. As Newman loops the track, he will sport a helmet with a design inspired by local veteran, Cpl. J.B. Kerns, USMC (Ret.) and Hope For The Warriors®, a national nonprofit organization that has assisted Kerns in receiving a new adaptive home earlier this month in nearby Arafat, VA.

Newman’s helmet is a spectacular red, white, and blue with design elements of the United States Flag. The helmet will be donated to Hope For The Warriors® and the nonprofit will auction the helmet at a later date to raise funds for future programs. Hope For The Warriors® is a national nonprofit dedicated to restoring a sense of self, restoring the family unit, and restoring hope for our service members and our military families.

Kerns received the keys to his new adaptive home, made possible in part by a donation of $ 50K from Hope For The Warriors®. The new home not only provides the OEF Veteran with customized appliances, it also placed him in a community that supports his service. Kerns served as a combat engineer and was on his third tour of duty in Afghanistan in April 2011 when he lost both legs and right arm to an IED. He has undergone dozens of surgeries since the injury and walks using artificial legs, a challenge that this “smart home” aims to tackle.

Hope For The Warriors® was pleased to be part of this connection process for Kerns. The nonprofit has already supported the rehabilitation of Kerns through its Sports & Recreation programs, engaging him with a visit to nearby Martinsville Speedway. There, Kerns first became involved with Hope For The Warriors® when he was the Grand Marshall.

The mission of Hope For The Warriors® (http://www.hopeforthewarriors.org) is to enhance the quality of life for post-9/11 service members, their families, and families of the fallen who have sustained physical and psychological wounds in the line of duty. Hope For The Warriors® is dedicated to restoring a sense of self, restoring the family unit, and restoring hope for our service members and our military families.

Hope For The Warriors® has earned a Four-Star Rating from Charity Navigator (http://www.charitynavigator.org) for three consecutive years. Charity Navigator is an independent organization that evaluates fiscal responsibility and accountability of nonprofits.

Hope For The Warriors® (Federal Tax ID 20-5182295) is a 501(c)(3) tax-exempt charity as defined in sections 509(A)(1) and 170(B)(1)(A)(VI) of the Internal Revenue Code. Combined Federal Campaign, CFC #27800.

                                                                                         ###







Home Care Assistance of Oklahoma to Offer Complimentary Continuing Education Unit (CEU) for Healthcare Professionals


Edmond, OK (PRWEB) October 13, 2014

Home Care Assistance of Oklahoma, North America’s premier provider of in-home care for seniors, is hosting an hour-long webinar, “Dementia Examined: Exploring Approaches for Treatment”, for CE credit. Led by Dr. Samuel Gontkovsky, Executive Director of Research and Development at Home Care Assistance, the webinar will provide an overview of the diagnostic criteria for dementia with an emphasis on the cognitive, behavioral and emotional issues that accompany the various forms of the disorder (e.g., Alzheimer’s disease, Lewy body disease, etc.). Dr. Gontkovsky will also discuss current treatments, both pharmacological and non-pharmacological, available for individuals with any form of dementia. Scientific studies will also be presented concerning neuroplasticity and the manner in which engagement in specific activities, or interventions, can promote structural and physiological changes in the brain that may in turn increase functioning and enhance quality of life. To register for the webinar, please visit http://bit.ly/ceuwebinar.

“We are very excited to offer this webinar to healthcare professionals who work closely with older adults,” said Dr. Samuel Gontkovsky. “Pharmacological interventions have been and continue to be the first-line treatment for chronic dementia, but recent research based on the concept of neuroplasticity suggests that various non-pharmacological interventions may be of substantial benefit for many people with this condition.”

This CEU course is offered free to all registrants as part of Home Care Assistance’s mission to change the way the world ages and commitment to community education around topics related to aging and wellness. This webinar is the ideal opportunity for professionals from a wide spectrum of fields, ranging from social workers to nurses to care managers and many more, to earn one CEU while simultaneously gaining valuable information that will be beneficial in advancing their careers and strengthening their patient relationships.

By the end of the presentation, webinar attendees will be able to:

    Describe different forms of dementia (e.g., Alzheimer’s disease, Lewy body disease, etc.) and associated cognitive, psychological and behavioral symptoms
    Have a comprehensive understanding of pharmacological and non-pharmacological approaches to dementia intervention
    Understand neuroplasticity and how specific activities may promote physiological changes in the brain that result in improved function and increased quality of life

“This complementary webinar will help spread research-based education to health care professionals working with dementias,” said Greg Bridges, local owner of Home Care Assistance in Edmond. “We want to be a resource to health professionals as well as families in our community on aging issues, and we hope many people can take advantage of this opportunity to earn continuing education credit,” he said.

The CEU is available if the healthcare professional is licensed in a field or profession from one of the boards listed below. Professionals who are not sure whether their state board will accept this CEU should contact the organization before registering:

-Social Work (NASW)

-Social Work Board

-Nursing (GNA/ANCC)

-Case Management (CCMC)

In order to receive one hour of CE credit, healthcare professionals must attend the full webinar, complete an evaluation and score 80% or higher on the post-test. The post-test must be completed by 5pm Pacific/8pm Eastern, on Wednesday, October 29th, 2014. Attendees who pass will receive their certificates via email.

For more information about Home Care Assistance of Oklahoma or the upcoming webinar, please visit http://www.HomeCareAssistanceOklahoma.com or call 405-285-4191.

ABOUT HOME CARE ASSISTANCE

Home Care Assistance is the leading provider of home care for seniors across the United States and Canada. Our mission is to change the way the world ages. We provide older adults with quality care that enables them to live happier, healthier lives at home. Our services are distinguished by the caliber of our caregivers, the responsiveness of our staff and our expertise in Live-In care. We embrace a positive, balanced approach to aging centered on the evolving needs of older adults. A 2014 Franchise500® and Inc. 5000 Company, Home Care Assistance has received numerous industry awards including Entrepreneur’s Fastest-Growing Franchises and Franchise Business Review’s Top 50. Home Care Assistance is also the exclusive provider of the Cognitive Therapeutics Method™, a one-on-one cognitive activities program administered in the home. For more information about Home Care Assistance or our services including the Cognitive Therapeutics Method™, visit homecareassistance.com or cognitivetherapeutics.com.







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author







Alleged Overuse of Risperdal and Other Medications Sparks Federal Nursing Home Lawsuit, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) September 08, 2014

Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District Court, Northern District of California, a number of elderly residents at the two facilities were allegedly treated with antipsychotic, psychotropic, and/or narcotic medications without the consent of their physicians or family members. In one case, an 86-year-old man became bedridden, stopped eating and developed bedsores and infections after he was treated with Risperdal and Haldol to control agitation. Within weeks of his admission to the facility, the resident was rushed to the hospital with symptoms of heart failure, a known side effect of antipsychotics in the elderly, the complaint charges.(Case No. 3:14-cv-03946)

According to a report from NPR, advocates for nursing home patients are hopeful that prosecutions such as this will discourage skilled nursing facilities from overmedicating their residents. While the labels for antipsychotic drugs like Risperdal warn that they can increase the risk of death in elderly dementia patients, about a fifth of nursing home residents nationwide are treated with such medications.*

“The filing of this complaint comes as hundreds of people pursue individual Risperdal lawsuits for gynecomastia and other complications allegedly caused by the antipsychotic medication. Among other things, these claims charge that the drug was improperly marketed for unapproved uses, including the treatment of elderly dementia patients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.

Risperdal Gynecomastia Litigation

Court records indicate that the majority of individual Risperdal lawsuits are pending in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of failing to warn doctors and patients about this potential risk. (In Re: Risperdal Litigation, Case Number 100300296).

In November 2013, Johnson & Johnson agreed to pay $ 2.2 million to settle charges brought by the U.S. Department of Justice involving the marketing of Risperdal and other medications. Among other things, the company pled guilty to a criminal misdemeanor and acknowledged that it had improperly marketed Risperdal for use in elderly dementia patients. However, Johnson & Johnson did not admit any wrongdoing in resolving civil charges regarding the promotion of Risperdal for off-label use in children. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to compensation for medical bills, lost wages, pain and suffering, emotional distress and more. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*ripr.org/post/feds-hope-hitting-nursing-homes-wallet-will-cut-overmedication, NPR, September 8, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

info (at) consumerinjurylawyers (dot) com

http://www.therisperdallawsuit.com/

https://plus.google.com/115936073311125306742?rel=author